XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Cumulative Effect, Period of Adoption, Adjustment
Total
Increase (Decrease) in Temporary Equity [Roll Forward]                
Contributions from noncontrolling interests               $ 18,829
Additional paid in capital attributable to redeemable noncontrolling interests               171
Balance at the end of the period at Jun. 30, 2022               19,000
Balance at the beginning of the period at Dec. 31, 2021 $ 566 $ 1,663,324   $ 59,368 $ (40,980) $ 2,924   1,685,202
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income       47,551   67   47,618
Issuance of common stock, net / amortization 55 312,780       333   313,168
Dividends declared       (21,514)       (21,514)
Change in accumulated other comprehensive income (loss)         13,030     13,030
Contributions from noncontrolling interests           18   18
Distributions to noncontrolling interests           (22)   (22)
Additional paid in capital attributable to redeemable noncontrolling interests   (171)           (171)
Balance at the end of the period at Jun. 30, 2022 621 1,975,933   85,405 (27,950) 3,320   2,037,329
Balance at the beginning of the period at Mar. 31, 2022               19,000
Balance at the end of the period at Jun. 30, 2022               19,000
Balance at the beginning of the period at Mar. 31, 2022 619 1,970,443   73,711 (35,691) 3,245   2,012,327
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income       22,678   33   22,711
Issuance of common stock, net / amortization 2 5,490       53   5,545
Dividends declared       (10,984)       (10,984)
Change in accumulated other comprehensive income (loss)         7,741     7,741
Distributions to noncontrolling interests           (11)   (11)
Balance at the end of the period at Jun. 30, 2022 621 1,975,933   85,405 (27,950) 3,320   2,037,329
Balance at the beginning of the period at Dec. 31, 2022 [1]               19,011
Balance at the end of the period at Jun. 30, 2023 [1]               19,011
Balance at the beginning of the period at Dec. 31, 2022 624 1,986,417 $ (640) 151,226 3,281 4,056 $ (640) 2,145,604 [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income       26,812   15   26,827
Issuance of common stock, net / amortization 3 14,128       497   14,628
Dividends declared       (22,572)       (22,572)
Change in accumulated other comprehensive income (loss)         5,838     5,838
Contributions from noncontrolling interests   (1,443)       30,439   28,996
Distributions to noncontrolling interests           (527)   (527)
Merger consideration (refer to Note 1) 12 35,576           35,588
Balance at the end of the period at Jun. 30, 2023 639 2,034,678   154,826 9,119 34,480   2,233,742 [1]
Balance at the beginning of the period at Mar. 31, 2023               19,011
Balance at the end of the period at Jun. 30, 2023 [1]               19,011
Balance at the beginning of the period at Mar. 31, 2023 639 2,031,026   144,164 (24,200) 27,498   2,179,127
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income       22,130   (19)   22,111
Issuance of common stock, net / amortization   3,652       488   4,140
Dividends declared       (11,468)       (11,468)
Change in accumulated other comprehensive income (loss)         33,319     33,319
Contributions from noncontrolling interests           6,525   6,525
Distributions to noncontrolling interests           (12)   (12)
Balance at the end of the period at Jun. 30, 2023 $ 639 $ 2,034,678   $ 154,826 $ 9,119 $ 34,480   $ 2,233,742 [1]
[1] Refer to Note 2 for details on the Company’s consolidated variable interest entities (“VIEs”).